SARS-CoV-2 vaccination and infection in ozanimod-treated participants with relapsing multiple sclerosis
Description
OBJECTIVE: To investigate the serologic response, predictors of response, and clinical outcomes associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and infection in ozanimod-treated participants with relapsing
